✦ LIBER ✦

Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial

✍ Scribed by Hara, Masako; Ishiguro, Naoki; Katayama, Kou; Kondo, Masakazu; Sumida, Takayuki; Mimori, Tsuneyo; Soen, Satoshi; Nagai, Kota; Yamaguchi, Tomonobu; Yamamoto, Kazuhiko

Book ID: 121761465
Publisher: Springer
Year: 2013
Tongue: English
Weight: 337 KB
Volume: 24
Category: Article
ISSN: 1439-7595
DOI: 10.3109/14397595.2013.843756

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant iguratimod therapy in patien

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial

✍ Ishiguro, Naoki; Yamamoto, Kazuhiko; Katayama, Kou; Kondo, Masakazu; Sumida, Tak 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 325 KB

Efficacy of methotrexate treatment in pa

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial

✍ R. F. van Vollenhoven; N. Kinnman; E. Vincent; S. Wax; J. Bathon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 2 views

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

A randomized, double-blind, and placebo-

A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate

✍ Fan, Wei; Zhao, Dong-bao; Hu, Shao-Xian; Xu, Hu-ji; Zhang, Xiao; Zhang, Miu-jia; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 632 KB